Breast Cancer News and Research

Latest Breast Cancer News and Research

Amgen announces European approval of Prolia

Amgen Inc. today announced that the European Commission (EC) has granted marketing authorization for Prolia® (denosumab) for the treatment of osteoporosis in postmenopausal women at increased risk of fractures, and for the treatment of bone loss associated with hormone ablation in men with prostate cancer at increased risk of fractures.

28 May 2010

Positron Emission Mammography helps evaluate response to neoadjuvant chemotherapy: Study

In a recent study presented at the American Association of Cancer Research Annual Meeting in Washington, DC, researchers at the University of Texas MD Anderson Cancer Center showed that Positron Emission Mammography (PEM) helps evaluate response to neoadjuvant chemotherapy.

28 May 2010

Active charity supporter nominated for Breast Cancer Campaign's Fundraiser of the Year award

An active charity supporter has been nominated for Breast Cancer Campaign's 'Fundraiser of the Year' award after raising more than £7,500 to help the charity continue funding vital breast cancer research.

27 May 2010

Local school nominated for Breast Cancer Campaign's School of the Year award

A local school has been nominated for Breast Cancer Campaign's 'School of the Year' award after raising more than £6,500 to help the charity continue funding vital breast cancer research.

27 May 2010

Genentech uses Complete Genomics' sequencing service to compare primary lung tumor, adjacent normal tissue

Complete Genomics Inc., a third-generation human genome sequencing company, today announced that Genentech Inc., a wholly owned member of the Roche Group, used the company's sequencing, bioinformatics and analytics services to sequence and compare a patient's primary lung tumor and adjacent normal tissue.

27 May 2010

Local businesswoman nominated for Outstanding Contribution to Breast Cancer Campaign 2010 Award

A local businesswoman has been nominated for the Outstanding Contribution to Breast Cancer Campaign 2010 Award after raising more than £15,000 for the charity through her passion for dolls houses and miniatures.

27 May 2010

Study finds improvement in detection of breast cancer in mammograms over 9-year period

Researchers analyzing 2.5 million screening mammograms performed on nearly one million women found discrimination of cancerous from non-cancerous lesions improved over a nine-year period. Results of the study are published in the online edition of the journal Radiology.

27 May 2010

Study assesses possible links between pain medications and recurrent breast cancer risk

Women who receive one common pain drug during mastectomy are less likely to develop recurrent breast cancer in the years following surgery, suggests a study in the June issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

27 May 2010

Breast-conserving therapy is viable treatment option for African-American women: Researchers

Breast-conserving therapy is a viable treatment option for African-American women, although they tend to have more advanced breast cancer at diagnosis, according to researchers from Beaumont Hospitals, Royal Oak, Mich. The study is available online now and will be in the July 15 issue of the journal Cancer.

26 May 2010

Highlights from June 2010 issue of American Journal of Pathology

Dr. Kanneboyina Nagaraju and colleagues at the Children's National Medical Center, Washington, DC demonstrate that affected muscle may directly contribute to inflammation in muscular dystrophy. Their report can be found in the June 2010 issue of The American Journal of Pathology.

26 May 2010

Targeted enrollment in Phase IIb trial for EpiCept NP-1 in CPN attained: EpiCept

EpiCept Corporation today announced that the targeted enrollment in a Phase IIb trial for EpiCept NP-1 in chemotherapy-induced peripheral neuropathy has been attained. The trial is being conducted by National Cancer Institute -funded Community Clinical Oncology Program.

26 May 2010

RCSI researchers identify biomarker that can predict severity of breast cancer

Researchers from the Royal College of Surgeons in Ireland have identified a biomarker in patient blood which can predict the severity of breast cancer in patients and may enable clinicians to track patients throughout the course of their treatment.

26 May 2010

State Roundup: Oklahoma, S.C. and Ill. facing tough choices on health costs

States around the country are debating how to deal with health costs and tight budgets.

26 May 2010

Nanoliposomes engineered to deliver therapeutic drugs that kill malignant cells

A new way to deliver cancer-fighting drugs using tiny particles made from lipids and chemotherapy drugs may have the power to knock out malignancies with a one-two punch. The strategy holds promise for patients with many different kinds of cancers.

25 May 2010

ImmunoGen to present clinical data on IMGN388 solid tumor compound at 2010 ASCO

ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, announced today that there will be several clinical data presentations for compounds utilizing the Company's Targeted Antibody Payload (TAP) technology at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO) being held in Chicago on June 4-8, 2010.

25 May 2010

Regulators puzzling out what insurers must do under new health law

The Washington Post reports that regulators are "trying to resolve" which insurance plans must comply with the health law's new requirements. "In keeping with President Obama's promise that you can hold on to your insurance if you like it, the new law exempts existing health plans from many of its provisions. But the law leaves it to regulators to decide how much a health plan can change without giving up its grandfathered status."

25 May 2010

Delphinus Medical Technologies secures $8M in venture capital to commercialize SoftVue system

The Barbara Ann Karmanos Cancer Institute announced today that its spin-off company Delphinus Medical Technologies, LLC, has secured $8 million in venture capital to start the commercialization process of SoftVue, an alternative to mammography.

25 May 2010

Scientists develop DNA-vaccine that restricts supply of blood to tumours

A DNA-vaccine that restricts the supply of blood to tumours has been developed by scientists at the Swedish medical university Karolinska Institutet. The vaccine slows the growth of breast cancer tumours in mice.

24 May 2010

Abviva receives new patent grant notifications for MSA technology

Abviva, Inc., a biomedical company engaged in the development and commercialization of breast cancer related applications of Mammastatin, today provided further details about worldwide patent protection for its breast cancer risk assessment technology.

24 May 2010

Women exposed prenatally to BPA or DES at increased risk of breast cancer: Study

A study in mice reveals that prenatal exposure to endocrine-disrupting chemicals, like bisphenol-A and diethylstilbestrol, may program a fetus for life. Therefore, adult women who were exposed prenatally to BPA or DES could be at increased risk of breast cancer, according to a new study accepted for publication in Hormones & Cancer, a journal of The Endocrine Society.

21 May 2010

Breast Cancer News and Research

Latest Breast Cancer News and Research

Amgen announces European approval of Prolia

Positron Emission Mammography helps evaluate response to neoadjuvant chemotherapy: Study

Active charity supporter nominated for Breast Cancer Campaign's Fundraiser of the Year award

Local school nominated for Breast Cancer Campaign's School of the Year award

Genentech uses Complete Genomics' sequencing service to compare primary lung tumor, adjacent normal tissue

Local businesswoman nominated for Outstanding Contribution to Breast Cancer Campaign 2010 Award

Study finds improvement in detection of breast cancer in mammograms over 9-year period

Study assesses possible links between pain medications and recurrent breast cancer risk

Breast-conserving therapy is viable treatment option for African-American women: Researchers

Highlights from June 2010 issue of American Journal of Pathology

Targeted enrollment in Phase IIb trial for EpiCept NP-1 in CPN attained: EpiCept

RCSI researchers identify biomarker that can predict severity of breast cancer

State Roundup: Oklahoma, S.C. and Ill. facing tough choices on health costs

Nanoliposomes engineered to deliver therapeutic drugs that kill malignant cells

ImmunoGen to present clinical data on IMGN388 solid tumor compound at 2010 ASCO

Regulators puzzling out what insurers must do under new health law

Delphinus Medical Technologies secures $8M in venture capital to commercialize SoftVue system

Scientists develop DNA-vaccine that restricts supply of blood to tumours

Abviva receives new patent grant notifications for MSA technology

Women exposed prenatally to BPA or DES at increased risk of breast cancer: Study

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Breast Cancer News and Research

Latest Breast Cancer News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in